These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3559270

  • 1. In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects.
    Puri N, Mojamdar M, Ramaiah A.
    J Invest Dermatol; 1987 Apr; 88(4):434-8. PubMed ID: 3559270
    [Abstract] [Full Text] [Related]

  • 2. Growth defects of melanocytes in culture from vitiligo subjects are spontaneously corrected in vivo in repigmenting subjects and can be partially corrected by the addition of fibroblast-derived growth factors in vitro.
    Puri N, Mojamdar M, Ramaiah A.
    Arch Dermatol Res; 1989 Apr; 281(3):178-84. PubMed ID: 2774645
    [Abstract] [Full Text] [Related]

  • 3. Successful culture of adult human melanocytes obtained from normal and vitiligo donors.
    Medrano EE, Nordlund JJ.
    J Invest Dermatol; 1990 Oct; 95(4):441-5. PubMed ID: 1698887
    [Abstract] [Full Text] [Related]

  • 4. Growth of human melanocytes from suction blister of localized vitiligo patient and from foreskins of newborns and adults by modified culture medium.
    Jee SH, Kuo YF, Wu YC, Chang CH, Kuo WL, Lü YC.
    J Formos Med Assoc; 1993 Jan; 92(1):7-14. PubMed ID: 8099831
    [Abstract] [Full Text] [Related]

  • 5. Culture of melanocytes obtained from normal and vitiligo subjects.
    Im S, Hann SK, Park YK, Kim HI.
    Yonsei Med J; 1992 Dec; 33(4):344-50. PubMed ID: 1309014
    [Abstract] [Full Text] [Related]

  • 6. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM.
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [Abstract] [Full Text] [Related]

  • 7. A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin.
    Ding GZ, Zhao WE, Li X, Gong QL, Lu Y.
    Arch Dermatol Res; 2015 Apr; 307(3):281-9. PubMed ID: 25672813
    [Abstract] [Full Text] [Related]

  • 8. Altered levels of LXR-α: crucial implications in the pathogenesis of vitiligo.
    Kumar R, Parsad D, Kanwar AJ, Kaul D.
    Exp Dermatol; 2012 Nov; 21(11):853-8. PubMed ID: 23163651
    [Abstract] [Full Text] [Related]

  • 9. Histopathologic features in vitiligo.
    Kim YC, Kim YJ, Kang HY, Sohn S, Lee ES.
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker.
    Kubanov A, Proshutinskaia D, Volnukhin V, Katunina O, Abramova T.
    Acta Dermatovenerol Alp Pannonica Adriat; 2016 Apr; 25(1):5-9. PubMed ID: 27014772
    [Abstract] [Full Text] [Related]

  • 11. Endothelin-1 and its A and B receptors: are they possibly involved in vitiligo?
    Aly DG, Salem SA, Abdel-Hamid MF, Youssef NS, El Shaer MA.
    Acta Dermatovenerol Croat; 2013 Apr; 21(1):12-8. PubMed ID: 23683481
    [Abstract] [Full Text] [Related]

  • 12. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
    Xiong XX, Ding GZ, Zhao WE, Li X, Ling YT, Sun L, Gong QL, Lu Y.
    Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
    [Abstract] [Full Text] [Related]

  • 13. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease.
    Bessou S, Gauthier Y, Surlève-Bazeille JE, Pain C, Taïeb A.
    Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904
    [Abstract] [Full Text] [Related]

  • 14. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
    Prignano F, Pescitelli L, Becatti M, Di Gennaro P, Fiorillo C, Taddei N, Lotti T.
    J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
    [Abstract] [Full Text] [Related]

  • 15. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG, Maraee AH, Shoeib MA, Elbana R.
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [Abstract] [Full Text] [Related]

  • 16. Short- and long-term effects of acetylsalicylic acid treatment on the proliferation and lipid peroxidation of skin cultured melanocytes of active vitiligo.
    Zailaie MZ.
    Saudi Med J; 2004 Nov; 25(11):1656-63. PubMed ID: 15573197
    [Abstract] [Full Text] [Related]

  • 17. Clinical and histopathologic characteristics of trichrome vitiligo.
    Hann SK, Kim YS, Yoo JH, Chun YS.
    J Am Acad Dermatol; 2000 Apr; 42(4):589-96. PubMed ID: 10727303
    [Abstract] [Full Text] [Related]

  • 18. Pigment cell transplantation for treatment of vitiligo: a progress report.
    Löntz W, Olsson MJ, Moellmann G, Lerner AB.
    J Am Acad Dermatol; 1994 Apr; 30(4):591-7. PubMed ID: 8157785
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension.
    Olsson MJ, Juhlin L.
    Br J Dermatol; 2002 Nov; 147(5):893-904. PubMed ID: 12410698
    [Abstract] [Full Text] [Related]

  • 20. Role of hair follicles in the repigmentation of vitiligo.
    Cui J, Shen LY, Wang GC.
    J Invest Dermatol; 1991 Sep; 97(3):410-6. PubMed ID: 1714927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.